Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBS-NN/NN2 Vaccine in Pregnant Women With and Without HIV
NCT04596878Phase 2Completed
- Sponsor
- MinervaX
- Start
- Nov 2020
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of GBS-NN/NN2 vaccine in group B streptococcal infection, sponsored by MinervaX. Started Nov 2020; status: completed.
02
Drugs
GBS-NN/NN2 vaccine
03
Conditions
group B streptococcal infection
Beyond the preview
Go deeper on NCT04596878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596878.